References and Notes
1a
Perry NB.
Blunt JW.
Munro MHG.
Sakai R.
J. Org. Chem.
1988,
53:
4127
1b
Konishi M.
Zercher CK.
Bechkam S.
Haubold E.-M.
J. Am. Chem. Soc.
1990,
112:
3715
1c
Wender PA.
Zercher CK.
Bechkam S.
Haubold E.-M.
J. Org. Chem.
1993,
58:
5867
1d
Uchida M.
Chihiro M.
Morita S.
Kanbe T.
Yamashita H.
Yamasakai K.
Yabuuchi Y.
Nakagawa K.
Chem. Pharm. Bull.
1989,
37:
2109
1e
Carling RW.
Leeson PD.
Mosely AM.
Smith JD.
Saywell K.
Tricklebank MD.
Kemp JA.
Marshal GR.
Foster AC.
Grimwood S.
Bioorg. Med. Chem. Lett.
1993,
3:
65
1f
Kam T.-S.
Subramaniam G.
Tetrahedron Lett.
2004,
45:
3521
2a
Weinreb SM. In
Comprehensive Organic Synthesis
Vol. 5:
Trost BM.
Fleming I.
Pergamon;
Oxford:
1991.
p.401
2b
Bunce RA.
Herron DM.
Johnson LB.
Kotturi S.
J. Org. Chem.
2001,
66:
2822
2c
Jia X.
Lin H.
Huo C.
Zhang W.
Lu J.
Yang L.
Zhao G.
Liu Z.-L.
Synlett
2003,
1707
2d
Nagarajan R.
Magesh CJ.
Perumal PT.
Synthesis
2004,
69
2e
Yadav JS.
Reddy BVS.
Padmavani B.
Synthesis
2004,
405
2f
Ding K.
Flippen-Anderson J.
Deschamps JR.
Wang S.
Tetrahedron Lett.
2004,
45:
1027
2g
Fadel F.
Titouani SL.
Soufiaoui M.
Ajamay H.
Mazzah A.
Tetrahedron Lett.
2004,
45:
5905
2h
Ori M.
Toda N.
Takami K.
Tago K.
Kogen H.
Tetrahedron
2005,
61:
2075
2i
Zhang W.
Guo Y.
Liu Z.
Jin X.
Yang L.
Liu Z.-L.
Tetrahedron
2005,
61:
1325
3a
Katritzky AR.
Rachwal S.
Rachwal B.
Tetrahedron
1996,
52:
15031
3b
Baraznenok IL.
Nenajdenko VG.
Churakov AV.
Nesterenko PN.
Balenkova ES.
Synlett
2000,
514
3c
De D.
Seth M.
Bhadori AP.
Indian J. Chem., Sect. B: Org. Chem. Incl. Med. Chem.
1990,
29:
70
3d
Lombardo LJ.
Camuso A.
Clark J.
Fager K.
Gullo-Brown J.
Hunt JT.
Inigo I.
Kan D.
Koplowitz B.
Lee F.
McGlinchey K.
Qian L.
Ricca C.
Rovnyak G.
Traeger S.
Tokarski J.
Williams DK.
Wu LI.
Zhao Y.
Manne V.
Bhide RS.
Bioorg. Med. Chem. Lett.
2005,
15:
1895
3e
Santangelo F.
Casagrande C.
Miragoli G.
Vecchietti V.
Eur. J. Med. Chem.
1994,
29:
877
3f
Lewis RJ.
Francis ChA.
Lehr RE.
Blank CL.-R.
Tetrahedron
2000,
56:
5345
4
General Procedure for Preparation of 1′,4′-dihydro-2
H
,2′
H
,6
H
-spiro[cyclohexane-1,3′-quinoline]-2,6-diones (4a-i).
A solution of amine 1 (2 mmol) and paraformaldehyde (8 mmol) in EtOH (25 mL) was prepared by gentle warming (2-3 min). Diketone 3 (2 mmol) was added to this solution in one portion and the mixture was heated under reflux for 5 min. After cooling to r.t. the colourless precipitate was filtered off, washed with EtOH (2 × 5 mL) and dried to give 4. The yields reported in Table
[1]
are unoptimised and additional crops of 4 could be obtained upon concentration of the mother liquors.
5a
Abdel-Magid AF.
Carson KG.
Harris BD.
Maryanoff CA.
Shah RD.
J. Org. Chem.
1996,
61:
3849
5b
Abdel-Magid AF.
Maryanoff CA.
Carson KG.
Tetrahedron Lett.
1990,
31:
5595
5c
Salvatore RN.
Yoon ChH.
Jung KW.
Tetrahedron
2001,
57:
7785
6 The N-monosubstituted anilines were prepared by reductive amination of the desired ketones with the corresponding primary anilines. Sodium triacetoxyborohydride was used as a reducing agent in the reaction as reported in ref. 5a.
7 All new compounds gave satisfactory 500 MHz 1H NMR and 100 MHz 13C NMR and IR spectral data.
Selected Physical Data.
1′-(1,3-Benzodioxol-5-ylmethyl)-6′-methoxy-1′,4′-dihydro-2
H
,2′
H
,6
H
-spiro[cyclohexane-1,3′-quinoline]-2,6-dione (
4b).
Mp 148 °C. IR (KBr): 3439, 3404, 2931, 2904, 2830, 1726, 1701, 1504, 1489, 1444, 1242, 1151, 1036 cm-1. 1H NMR (CDCl3): δ = 1.82 (m, 1 H), 2.02 (m, 1 H), 2.60-2.75 (m, 4 H), 3.21 (s, 2 H), 3.46 (s, 2 H), 3.75 (s, 3 H), 4.30 (s, 2 H), 5.95 (s, 2 H), 6.55-6.63 (m, 2 H), 6.71-6.80 (m, 4 H). 13C NMR (CDCl3): δ = 19.05, 30.64, 37.86, 55.21, 56.25, 56.33, 67.07, 101.69, 108.37, 109.03, 113.10, 113.72, 115.39, 120.92, 123.33, 132.85, 139.13, 147.41, 148.70, 152.88, 206.33. MS (70 eV): m/z (%) = 135 (82), 252 (100), 393 (23) [M+], 394 (5) [M + H+]. Anal. Calcd for C23H23NO5: C, 70.21; H, 5.89; N, 3.56. Found: C, 70.21; H, 5.90; N, 3.57.
1′-(3,4-Dimethoxybenzyl)-6′-methoxy-4,4-dimethyl-1′,4′-dihydro-2
H
,2′
H
,6
H
-spiro[cyclohexane-1,3′-quinoline]-2,6-dione (
4g).
Mp 159 °C. IR (KBr): 2963, 2916, 2834, 1722, 1691, 1511, 1459, 1259, 1229, 1201, 1160, 1137, 1053, 1026 cm-1. 1H NMR (CDCl3): δ = 0.88 (s, 3 H), 1.05 (s, 3 H), 2.43 (d, J = 14.0 Hz, 2 H), 2.63 (d, J = 14.0 Hz, 2 H), 3.20 (s, 2 H), 3.41 (s, 2 H), 3.75 (s, 3 H), 3.85 (s, 3 H), 3.89 (s, 3 H), 4.31 (s, 2 H), 6.55-6.63 (m, 2 H), 6.76-6.86 (m, 4 H). 13C NMR (CDCl3): δ = 27.77, 29.99, 30.62, 31.51, 51.65, 55.51, 55.90, 56.24, 56.57, 56.65, 65.89, 66.51, 110.96, 111.83, 112.95, 113.64, 115.37, 119.98, 123.65, 131.53, 139.32, 148.83, 150.04, 152.93, 206.16. MS (70 eV): m/z (%) = 151 (100), 252 (63), 437 (12) [M+], 438 (3) [M + H+]. Anal. Calcd for C26H31NO5: C, 71.37; H, 7.14; N, 3.20. Found: C, 71.37; H, 7.14; N, 3.21.
1′-Cyclododecyl-6′-methoxy-1′,4′-dihydro-2
H
,2′
H
,6
H
-spiro[cyclohexane-1,3′-quinoline]-2,6-dione (
4i).
Mp 186 °C. IR (KBr): 3431, 2937, 2925, 2859, 1717, 1692, 1611, 1580, 1505, 1256, 1239, 1052 cm-1. 1H NMR (CDCl3): δ = 1.30-1.50 (m, 20 H), 1.59-1.70 (m, 2 H), 1.74-1.88 (m, 1 H), 2.06-2.18 (m, 1 H), 2.62-2.67 (m, 2 H), 2.81-2.87 (m, 2 H), 3.15 (s, 2 H), 3.35 (s, 2 H), 3.74 (s, 3 H), 3.88 (t, J = 5.8 Hz, 1 H), 6.68 (br s, 2 H), 6.37 (s, 1 H). 13C NMR (CDCl3): δ = 18.31, 22.47, 22.60, 23.01, 23.77, 23.97, 26.42, 29.65, 37.22, 48.07, 50.91, 55.42, 65.98, 111.58, 112.12, 115.02, 123.10, 138.75, 151.28, 205.74. Anal. Calcd for C27H39NO3: C, 76.20; H, 9.24; N, 3.29. Found: C, 76.21; H, 9.22; N, 3.28.
1′-(5,5,6-Trimethylbicyclo[2.2.1]hept-2-yl)-6′-methyl-1′,4′-dihydro-2
H
,2′
H
,6
H
-spiro[cyclohexane-1,3′-quinoline]-2,6-dione (
4j).
Mp 156 °C. IR (KBr): 3407, 2964, 2893, 2865, 2833, 1728, 1702, 1619, 1505, 1416, 1265, 1170, 1019, 819, 812 cm-1. 1H NMR (CDCl3): δ = 0.87 (s, 3 H), 0.91 (s, 3 H), 1.03 (d, J = 7.5 Hz, 3 H), 1.31 (dd, J = 1.1, 10.3 Hz, 1 H), 1.49 (dt, J = 3.6, 13.0 Hz, 1 H), 1.70 (d, J = 3.7 Hz, 1 H), 1.75-1.95 (m, 3 H), 2.00 (dq, J = 1.1, 7.4 Hz, 1 H), 2.05-2.13 (m, 1 H), 2.16 (d, J = 2.0 Hz, 1 H), 2.26 (s, 3 H), 2.51 (dt, J = 5.3, 15.5 Hz, 1 H), 2.72 (dt, J = 5.3, 15.5 Hz, 1 H), 2.81-2.97 (m, 2 H), 2.88 (d, J = 11.0 Hz, 1 H), 2.91 (d, J = 13.0 Hz, 1 H), 3.16 (d, J = 13.0 Hz, 1 H), 3.36 (dt, J = 3.9, 9.7 Hz, 1 H), 3.71 (d, J = 11.0 Hz, 1 H), 6.61 (d, J = 8.0 Hz, 1 H), 6.85 (s, 1 H), 6.97 (d, J = 8.0 Hz, 1 H). 13C NMR (CDCl3): δ = 15.81, 17.96, 20.50, 24.72, 26.31, 32.46, 34.84, 35.80, 37.03, 37.40, 37.88, 39.67, 48.17, 49.38, 49.93, 60.55, 71.76, 114.87, 125.63, 127.47, 127.86, 128.07, 146.13, 205.77, 206.23. Anal. Calcd for C25H33NO2: C, 79.11; H, 8.76; N, 3.69. Found: C, 79.10; H, 8.74; N, 3.70.
1′-(2-Adamantyl)-6′-methyl-4,4-dimethyl-1′,4′-dihydro-2
H
,2′
H
,6
H
-spiro[cyclohexane-1,3′-quinoline]-2,6-dione (
4k).
Mp 205 °C. IR (KBr): 3440, 2919, 2900, 2862, 1725, 1695, 1502, 1248, 1155, 819, 519 cm-1. 1H NMR (CDCl3): δ = 0.94 (s, 3 H), 1.07 (s, 3 H), 1.56 (d, J = 12.5 Hz, 2 H), 1.75 (s, 2 H), 1.83-1.96 (m, 6 H), 2.06 (d, J = 12.5 Hz, 2 H), 2.24 (s, 3 H), 2.28 (br s, 2 H), 2.56 (d, J = 14.0 Hz, 2 H), 2.80 (d, J = 14.0 Hz, 2 H), 3.05 (s, 2 H), 3.51 (s, 3 H), 6.56 (d, J = 8.0 Hz, 1 H), 6.88 (s, 1 H), 6.93 (d, J = 8 Hz, 1 H). 13C NMR (CDCl3): δ = 20.45, 27.02, 27.51, 28.02, 29.00, 29.77, 30.65, 32.26, 34.37, 37.57, 37.59, 46.18, 51.21, 60.98, 69.57, 114.64, 125.76, 127.58, 127.84, 128.30, 144.59, 206.01. Anal. Calcd for C27H35NO2: C, 79.96; H, 8.70; N, 3.45. Found: C, 80.00; H, 8.73; N, 3.42.
For the original work, see:
8a
Hofmann AW.
Martius CA.
Ber. Dtsch. Chem. Ges.
1871,
4:
742
8b For mechanistic considerations, see: Drumm PJ.
O’Connor WF.
Reilly J.
J. Am. Chem. Soc.
1940,
62:
1241
For synthetic applications of the rearrangement, see:
8c
Martínez R.
Cortés E.
Toscano RA.
Linzaga I.
J. Heterocycl. Chem.
1990,
27:
363
8d
Martínez R.
Cortés E.
Toscano RA.
Alfaro LJ.
J. Heterocycl. Chem.
1990,
27:
1273
8e
Martínez R.
Cortés E.
Toscano RA.
Alfaro LJ.
Avila JG.
J. Heterocycl. Chem.
1991,
28:
589
9 For chemistry of 2-azaspiro compounds, see: Alonso ER.
Tehrani KA.
Boelens M.
De Kimpe N.
Synthesis
2005,
1726 ; and literature cited therein